791OUpdated results of GETUG-12, a phase III trial of docetaxel-based chemotherapy in high-risk localized prostate cancer, with a 12-year follow-up

Authors

Keywords

Journal

Volume 29, Issue suppl_8, Pages -

Publisher

Oxford University Press (OUP)

Online

2018-10-25

DOI

10.1093/annonc/mdy284

Explore over 38,000 international journals covering a vast array of academic fields.

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now